RITUXAN therapy

Your follicular lymphoma journey begins with initial treatment

As initial treatment—RITUXAN, with CVP chemotherapy, may be given to treat follicular lymphoma. These drugs work together in different ways to fight cancer. The goal in using this combination of drugs is to keep your cancer from getting worse.

In one study, patients who received RITUXAN+CVP chemotherapy spent 1 year longer without their cancer advancing (compared with patients who received CVP chemotherapy by itself). These results were from a clinical trial and may not be the same as what you experience.

You will have up to 8 cycles, or rounds, of treatment. Each cycle will last 21 days. Treatment occurs on the first day of each cycle and is followed by 20 days of rest and recovery. This means that most people will complete their treatment in about 6 months.

Initial treatment infusion schedule for follicular lymphoma

PATIENTS MAY RECEIVE FEWER THAN 8 CYCLES OF RITUXAN IN COMBINATION WITH CHEMOTHERAPY.

Select Important Safety Information

RITUXAN for the treatment of follicular CD20-positive non-Hodgkin's lymphoma as an initial treatment with CVP chemotherapy

The most common side effects reported more often in patients receiving RITUXAN and CVP chemotherapy vs. CVP chemotherapy alone were infusion reactions, decreased white blood cell counts, rash, cough, flushing, shivering, itching, and chest tightness.

NEXT: Rituxan Maintenance Therapy

RITUXAN is available by prescription only.